Pay in 4 interest-free payments of $7.00 Learn more
Ships within 48 hours · Estimated delivery Aug 10 - Aug 15
A phase I study of intravenous artesunate in patients with advanced solid tumor malignancies
And researchers at Case Western Reserve University School of Medicine, Cleveland, Ohio, suggest that using GLP-1 drugs to lose wight may reduce the risk of 10 of those, including: Colorectal cancer Esophageal cancer Endometrial cancer Gallbladder cancer Kidney cancer Liver cancer Ovarian cancer Pancreatic cancer Meningioma Multiple myeloma These findings provide preliminary evidence of the potential benefit of GLP-1s for cancer prevention in high-risk populations and support further preclinical and clinical studies for the prevention of certain OACs, researchers say
2022 [cited 2023 Dec 4];23
Research indicates that these biological pathways contribute to its metabolic effects and clinical applications
US$ 21.91
US$ 22.66
US$ 21.96
US$ 23.22
US$ 27.17
